The functional relevance of restoration of NKG2D–NKG2DL interaction by gefitinib was demonstrated by the enhanced cytotoxicity, degranulation and IFN-γ production of NK cells in response to lung cancer cells with EGFR L858R + T790M resistance mutation. This evidence concerns the gene EGFR and lung carcinoma.